Does DACTINOMYCIN Cause Neoplasm progression? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Neoplasm progression have been filed in association with DACTINOMYCIN (DACTINOMYCIN). This represents 2.0% of all adverse event reports for DACTINOMYCIN.
57
Reports of Neoplasm progression with DACTINOMYCIN
2.0%
of all DACTINOMYCIN reports
17
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm progression From DACTINOMYCIN?
Of the 57 reports, 17 (29.8%) resulted in death, 7 (12.3%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACTINOMYCIN. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does DACTINOMYCIN Cause?
Off label use (391)
Febrile neutropenia (226)
Neutropenia (205)
Product use in unapproved indication (203)
Drug ineffective (181)
Disease progression (151)
Vomiting (119)
Anaemia (109)
Thrombocytopenia (106)
Malignant neoplasm progression (103)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which DACTINOMYCIN Alternatives Have Lower Neoplasm progression Risk?
DACTINOMYCIN vs DALBAVANCIN
DACTINOMYCIN vs DALFAMPRIDINE
DACTINOMYCIN vs DALTEPARIN
DACTINOMYCIN vs DAMOCTOCOG ALFA PEGOL
DACTINOMYCIN vs DANAPAROID